Skip to main content

Advertisement

SpringerLink
Log in

Cost-effectiveness of the Danish smoking cessation interventions

Subgroup analysis based on the Danish Smoking Cessation Database

  • Original Papers
  • Published:
The European Journal of Health Economics Aims and scope Submit manuscript

Abstract

The cost-effectiveness of smoking cessation interventions is well documented. However, most studies are based on randomized controlled trials (RCTs) and provide little information on the differences between subgroups. This study assessed the relative cost-effectiveness of smoking cessation interventions offered to various subgroups of smokers, based on real-life data. Regression analyses provided information on the factors determining abstinence and costs and led to the formation of relevant subgroups of smokers. Probabilistic Markov modeling was then used to estimate the relative cost-effectiveness of smoking cessation interventions for the entire database population and for the subgroups compared to a no-intervention case. The ICER for the base case population was estimated at €1,358. This is consistent with results from the existing literature. Group simulations showed lower ICERs for men, hospitals, and light smokers and falling ICERs with increasing age. Despite differences in the cost-effectiveness ratios between subgroups our results do not justify any kind of subgroup differentiation in a smoking prevention policy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Reference

  1. Song F, Raftery J, Aveyard P et al. (2002) Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis. Med Decis Making 22 [Suppl 5]: S26–S37

  2. Tran MT, Holdford DA, Kennedy DT, Small RE (2002) Modeling the cost-effectiveness of a smoking-cessation program in a community pharmacy practice. Pharmacotherapy 22: 1623–1631

    Article  PubMed  Google Scholar 

  3. Warner KE (1997) Cost effectiveness of smoking-cessation therapies. Interpretation of the evidence-and implications for coverage. Pharmacoeconomics 11: 538–549

    PubMed  Google Scholar 

  4. Altman DG, Flora JA, Fortmann SP, Farquhar John W (1987) The cost-effectiveness of three smoking cessation programs. Am J Public Health 77: 162–165

    PubMed  Google Scholar 

  5. Godfrey C, Parrott S, Coleman T, Pound E (2005) The cost-effectiveness of the English smoking treatment services: evidence from practice. Addiction 100 [Suppl 2]: 70–83

    Google Scholar 

  6. Prescott E, Osler M, Andersen PK et al. (1998) Mortality in women and men in relation to smoking. Int J Epidemiol 27: 27–32

    Article  PubMed  Google Scholar 

  7. Doll R, Peto R, Boreham J, Sutherland I (2004) Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ 328: 1519

    Article  PubMed  Google Scholar 

  8. PLS Consult (2004) Monitorering af danskernes rygevaner, Krydstabeller – alle respondenter. PLS Consult

  9. Crealey GE, McElnay JC, Maguire TA, O’Neill C (1998) Costs and effects associated with a community pharmacy-based smoking-cessation programme. Pharmacoeconomics 14: 323–333

    Article  PubMed  Google Scholar 

  10. Cromwell J, Bartosch WJ, Fiore MC et al. (1997) Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA 278: 1759–1766

    Article  PubMed  Google Scholar 

  11. Stapleton JA, Lowin A, Russell MA (1999) Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness. Lancet 354: 210–215

    Article  PubMed  Google Scholar 

  12. Sonnenberg FA, Beck JR (1993) Markov models in medical decision making: a practical guide. Med Decis Making 13: 322–338

    PubMed  Google Scholar 

  13. Pisinger C, Vestbo J, Borch-Johnsen K, Jorgensen T (2005) Smoking cessation intervention in a large randomised population-based study. The Inter99 study. Prev Med 40: 285–292

    Article  PubMed  Google Scholar 

  14. Pisinger C (2004) Smoking cessation and smoking reduction in a general population. The Inter99 study. Thesis, Copenhagen County

  15. Cornuz J, Pinget C, Gilbert A, Paccaud F (2003) Cost-effectiveness analysis of the first-line therapies for nicotine dependence. Eur J Clin Pharmacol 59: 201–206

    Article  PubMed  Google Scholar 

  16. Wasley MA, McNagny SE, Phillips VL, Ahluwalia JS (1997) The cost-effectiveness of the nicotine transdermal patch for smoking cessation. Prev Med 26: 264–270

    Article  PubMed  Google Scholar 

  17. Devlin N, Parkin D (2004) Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Econ 13: 437–452

    Article  PubMed  Google Scholar 

  18. Miller W, Rollnick S (2002) Motivational interviewing, preparing people for change, 2nd edn. New York, Guilford

  19. Barendregt JJ, Bonneux L, van der Maas PJ (1997) The health care costs of smoking. N Engl J Med 337: 1052–1057

    Article  PubMed  Google Scholar 

  20. Rasmussen SR, Prescott E, Sorensen TI, Sogaard J (2004) The total lifetime costs of smoking. Eur J Public Health 14: 95–100

    Article  PubMed  Google Scholar 

  21. Hoch JS, Briggs AH, Willan AR (2002) Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. Health Econ 11: 415–430

    Article  PubMed  Google Scholar 

  22. Willan AR, Briggs AH, Hoch JS (2004) Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data. Health Econ 13: 461–475

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

T.E., H.M., H.H.J., and H.H. designed the data collection in collaboration with the other members of the Danish National Smoking Cessation Database (DNSCD) Steering Committee. M.R. handled the DNSCD data collection. H.H.J. drafted the design of the economic analysis. L.B. carried out the literature review and collected, with assistance from N.T.K., model parameters from other sources than the DNSCD. K.R.O. designed and carried out the modeling and data analysis with assistance from L.B.. L.B. and K.R..O. drafted the manuscript with assistance from H.H.J., and all authors critically reviewed and finally approved the manuscript. The study was supported financially by the Danish Ministry of the Interior and Health, The Danish Institute for Health Services Research and the Clinical Unit of Health Promotion at Bispebjerg Hospital. We thank statistician Andreas Habicht for data management assistance and Susanne Reindahl Rasmussen from DSI for helpful discussions on the analysis. An earlier version of the manuscript was presented at the 2005 IHEA Conference, and we thank the session participants for their interest in the analysis.

Author information

Author notes

  1. Kim Rose Olsen

    Present address: DSI Danish Institute for Health Services Research, Dampfaergevej 27–29, 2100, Copenhagen Ø, Denmark

Authors and Affiliations

  1. Danish Institute for Health Services Research, Copenhagen, Denmark

    Kim Rose Olsen, Lone Bilde & Henrik Hauschildt Juhl

  2. Danish Cancer Society, Copenhagen, Denmark

    Niels Them Kjaer

  3. Copenhagen University Hospital, Copenhagen, Denmark

    Holger Mosbech

  4. County of Frederiksborg, Hillerød, Denmark

    Torben Evald & Helle Hiladakis

  5. Bispebjerg Hospital, Copenhagen, Denmark

    Mette Rasmussen

Authors
  1. Kim Rose Olsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lone Bilde
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Henrik Hauschildt Juhl
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Niels Them Kjaer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Holger Mosbech
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Torben Evald
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mette Rasmussen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Helle Hiladakis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kim Rose Olsen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Olsen, K.R., Bilde, L., Juhl, H.H. et al. Cost-effectiveness of the Danish smoking cessation interventions. Eur J Health Econ 7, 255–264 (2006). https://doi.org/10.1007/s10198-006-0362-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10198-006-0362-1

Keywords

Search

Navigation